IN THE NEWS
September 14, 2017:
Mustang Bio Announces Expansion of CAR T Pipeline into CD20-Directed Immunotherapies
September 11, 2017:
Checkpoint Therapeutics Receives Orphan Drug Designation for CK-101 for the Treatment of EGFR Mutation-Positive Non-Small Cell Lung Cancer
September 5, 2017:
Fortress Biotech to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
September 5, 2017:
Checkpoint Therapeutics to Present at the 19th Annual Rodman & Renshaw Global Investment Conference
September 5, 2017:
Mustang Bio to Present at the CAR-TCR Summit 2017
August 22, 2017:
Mustang Bio Commences Trading on the NASDAQ Global Market
QUICK LINKS
PIPELINE
